The Safety and Efficacy of Combination Therapy of Sorafenib and Radiotherapy for Advanced Hepatocellular Carcinoma: A Retrospective Study

OBJECTIVE: Sorafenib is a standard therapy for advanced hepatocellular carcinoma (HCC), whereas radiotherapy is effective for local control of extrahepatic spread (EHS) or macrovascular invasion (MVI). This study investigated the safety and efficacy of this combined therapy to treat advanced HCC. ME...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Intern Med
Glavni autori: Wada, Yoshiyuki, Takami, Yuko, Matsushima, Hajime, Tateishi, Masaki, Ryu, Tomoki, Yoshitomi, Munehiro, Matsumura, Taisei, Saitsu, Hideki
Format: Artigo
Jezik:Inglês
Izdano: The Japanese Society of Internal Medicine 2017
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5995712/
https://ncbi.nlm.nih.gov/pubmed/29279513
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2169/internalmedicine.9826-17
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items